{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:46:27Z","timestamp":1791009987395,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2019\/GNT1185399"],"award-info":[{"award-number":["2019\/GNT1185399"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.copbio.2026.103527","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:33:41Z","timestamp":1780576421000},"page":"103527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Bacteriophage nanoparticles: an emerging modular delivery platform"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8919-1924","authenticated-orcid":false,"given":"Linzi","family":"Whiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah X","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso E","family":"Garcia-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-1301","authenticated-orcid":false,"given":"Paul R","family":"Jaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2026.103527_sbref1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.copbio.2026.103527_sbref2","article-title":"Phage-based delivery systems: engineering, applications, and challenges in nanomedicines","volume":"22","author":"Wang","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.copbio.2026.103527_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.copbio.2020.11.003","article-title":"Enhancing phage therapy through synthetic biology and genome engineering","volume":"68","author":"Lenneman","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.copbio.2026.103527_bib4","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41564-022-01258-x","article-title":"Broad-spectrum CRISPR-Cas13a enables efficient phage genome editing","volume":"7","author":"Adler","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_sbref5","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt6432","article-title":"Engineering bacteriophages through deep mining of metagenomic motifs","volume":"11","author":"Huss","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.copbio.2026.103527_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-86112-6","article-title":"CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineering","volume":"11","author":"Wetzel","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2026.103527_sbref7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh1547","article-title":"A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering","volume":"7","author":"Zhu","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.copbio.2026.103527_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41568-025-00847-2","article-title":"Advancing engineering design strategies for targeted cancer nanomedicine","volume":"25","author":"Gomerdinger","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.copbio.2026.103527_bib9","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1021\/acsnano.9b00552","article-title":"Link between low-fouling and stealth: a whole blood biomolecular corona and cellular association analysis on nanoengineered particles","volume":"13","author":"Weiss","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.copbio.2026.103527_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1155622","article-title":"A review on nanoparticles: characteristics, synthesis, applications, and challenges","volume":"14","author":"Altammar","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_bib11","article-title":"Advancing cancer gene therapy: the emerging role of nanoparticle delivery systems","volume":"23","author":"Wang","year":"2025","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.copbio.2026.103527_bib12","article-title":"Multifunctional nanocarriers in bacteriophage delivery: a paradigm shift in treating multidrug-resistant infections","volume":"17","author":"Patil","year":"2025","journal-title":"Wiley Inter Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.copbio.2026.103527_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1462-2920.16207","article-title":"The global virome: how much diversity and how many independent origins?","volume":"25","author":"Koonin","year":"2023","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_sbref14","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adv0870","article-title":"RBPseg: toward a complete phage tail fiber structure atlas","volume":"11","author":"Klein-Sousa","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.copbio.2026.103527_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veae007","article-title":"The untapped potential of phage model systems as therapeutic agents","volume":"10","author":"Romeyer Dherbey","year":"2024","journal-title":"Virus Evol"},{"key":"10.1016\/j.copbio.2026.103527_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2024.102555","article-title":"Tapping the treasure trove of atypical phages","volume":"82","author":"Roux","year":"2024","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-023-02138-4","article-title":"Phage tailspike modularity and horizontal gene transfer reveals specificity towards E. coli O-antigen serogroups","volume":"20","author":"Pas","year":"2023","journal-title":"Virol J"},{"key":"10.1016\/j.copbio.2026.103527_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110148","article-title":"Discovery and characterisation of new phage targeting uropathogenic Escherichia coli","volume":"597","author":"Asgharzadeh Kangachar","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.copbio.2026.103527_sbref19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/acs.bioconjchem.1c00018","article-title":"Bacteriophage capsid modification by genetic and chemical methods","volume":"32","author":"Carmody","year":"2021","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.copbio.2026.103527_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tibs.2022.08.012","article-title":"High-throughput approaches to understand and engineer bacteriophages","volume":"48","author":"Huss","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.copbio.2026.103527_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/srep39235","article-title":"Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine","volume":"6","author":"Nobrega","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2026.103527_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70841-1","article-title":"Optimizing bacteriophage engineering through an accelerated evolution platform","volume":"10","author":"Favor","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2026.103527_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2022.101255","article-title":"Bacteriophage T4 as a nanovehicle for delivery of genes and therapeutics into human cells","volume":"55","author":"Rao","year":"2022","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.copbio.2026.103527_bib24","article-title":"Virus-like particles: revolutionary platforms for developing vaccines against emerging infectious diseases","volume":"12","author":"Tariq","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_sbref25","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.114006","article-title":"Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line models","volume":"28","author":"Batra","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.copbio.2026.103527_sbref26","article-title":"Design of bacteriophage T4-based artificial viral vectors for human genome remodeling","volume":"14","author":"Zhu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2026.103527_sbref27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","article-title":"In situ targeted base editing of bacteria in the mouse gut","volume":"632","author":"Brodel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2026.103527_sbref28","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102571","article-title":"A novel miniaturized filamentous phagemid as a gene delivery vehicle to target mammalian cells","volume":"36","author":"Wong","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.copbio.2026.103527_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43236-9","article-title":"Ongoing shuffling of protein fragments diversifies core viral functions linked to interactions with bacterial hosts","volume":"14","author":"Smug","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2026.103527_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.32607\/20758251-2016-8-1-48-57","article-title":"Phage peptide libraries as a source of targeted ligands","volume":"8","author":"Nemudraya","year":"2016","journal-title":"Acta Nat"},{"key":"10.1016\/j.copbio.2026.103527_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2026.02.001","article-title":"Phage therapy in oncology: opportunities for cancer prevention and treatment","author":"Mutalik","year":"2026","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.copbio.2026.103527_bib32","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/bc300130z","article-title":"M13 bacteriophage display framework that allows sortase-mediated modification of surface-accessible phage proteins","volume":"23","author":"Hess","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.copbio.2026.103527_bib33","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/acs.bioconjchem.7b00296","article-title":"Sortase-mediated ligation as a modular approach for the covalent attachment of proteins to the exterior of the bacteriophage P22 virus-like particle","volume":"28","author":"Patterson","year":"2017","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.copbio.2026.103527_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49233-7","article-title":"Integrating SpyCatcher\/SpyTag covalent fusion technology into phage display workflows for rapid antibody discovery","volume":"9","author":"Fierle","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2026.103527_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202570016","article-title":"A modular bacteriophage T4 nanoparticle platform enables rapid design of dual COVID-19-Flu mucosal vaccines","volume":"5","author":"Zhu","year":"2025","journal-title":"Small Sci"},{"key":"10.1016\/j.copbio.2026.103527_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.961093","article-title":"Expanding the chemical diversity of M13 bacteriophage","volume":"13","author":"Allen","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.699054","article-title":"Nanotechnology based approaches in phage therapy: overcoming the pharmacological barriers","volume":"12","author":"Kaur","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.copbio.2026.103527_bib38","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2022.05.021","article-title":"Paving the way for phage therapy using novel drug delivery approaches","volume":"347","author":"Briot","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.copbio.2026.103527_bib39","article-title":"Phage-inorganic hybrid magnetic nanorobots for enhanced antibacterial and antibiofilm activities","volume":"521","author":"Liu","year":"2025","journal-title":"Chem Eng J"},{"key":"10.1016\/j.copbio.2026.103527_bib40","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/jacs.9b12936","article-title":"Phage-guided targeting, discriminative imaging, and synergistic killing of bacteria by AIE bioconjugates","volume":"142","author":"He","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.copbio.2026.103527_bib41","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1073\/pnas.1913234117","article-title":"Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages","volume":"117","author":"Peng","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.copbio.2026.103527_bib42","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1007\/s00216-023-04606-w","article-title":"M13 phage: a versatile building block for a highly specific analysis platform","volume":"415","author":"Wang","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.copbio.2026.103527_bib43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/hum.2013.210","article-title":"Full-length dystrophin reconstitution with adeno-associated viral vectors","volume":"25","author":"Lostal","year":"2014","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.copbio.2026.103527_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax0064","article-title":"A prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells","volume":"5","author":"Zhu","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.copbio.2026.103527_sbref45","article-title":"Targeted treatment of chondrosarcoma with a bacteriophage-based particle delivering a secreted tumor necrosis factor-related apoptosis-inducing ligand","volume":"32","author":"Chongchai","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"10.1016\/j.copbio.2026.103527_bib46","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/bit.28402","article-title":"Process economics evaluation and optimization of adeno-associated virus downstream processing","volume":"121","author":"Lyle","year":"2024","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.copbio.2026.103527_bib47","series-title":"Building a Sustainable Ecosystem for Phage Therapy","author":"Lin","year":"2022"},{"key":"10.1016\/j.copbio.2026.103527_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002119","article-title":"Translating phage therapy into the clinic: recent accomplishments but continuing challenges","volume":"21","author":"Petrovic Fabijan","year":"2023","journal-title":"PLoS Biol"},{"key":"10.1016\/j.copbio.2026.103527_sbref49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41587-023-01759-y","article-title":"Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice","volume":"42","author":"Gencay","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2026.103527_sbref50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41587-025-02570-7","article-title":"Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage","volume":"44","author":"Baker","year":"2026","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2026.103527_sbref51","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-39612-0","article-title":"Enhancing bacteriophage therapeutics through in situ production and release of heterologous antimicrobial effectors","volume":"14","author":"Du","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2026.103527_bib52","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1021\/nn201397z","article-title":"Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles","volume":"5","author":"Ashley","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.copbio.2026.103527_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202422459","article-title":"High-fidelity in vitro packaging of diverse synthetic cargo into encapsulin protein cages","volume":"64","author":"Szyszka","year":"2025","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.copbio.2026.103527_bib54","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1039\/D3MA00817G","article-title":"Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects","volume":"5","author":"Emencheta","year":"2023","journal-title":"Mater Adv"},{"key":"10.1016\/j.copbio.2026.103527_bib55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.cmi.2023.01.021","article-title":"Pharmacokinetics\/pharmacodynamics of phage therapy: a major hurdle to clinical translation","volume":"29","author":"Nang","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.copbio.2026.103527_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1250848","article-title":"Regulations of phage therapy across the world","volume":"14","author":"Yang","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.copbio.2026.103527_bib57","doi-asserted-by":"crossref","first-page":"e1094","DOI":"10.1093\/infdis\/jiag096","article-title":"Immune responses to phage therapy in humans: a review","volume":"233","author":"Bosco","year":"2026","journal-title":"J Infect Dis"},{"key":"10.1016\/j.copbio.2026.103527_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/bioengineering12050469","article-title":"Bacteriophages as targeted therapeutic vehicles: challenges and opportunities","volume":"12","author":"Venkataraman","year":"2025","journal-title":"Bioengineering"},{"key":"10.1016\/j.copbio.2026.103527_bib59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2026.103527_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02071-21","article-title":"Considerations for the use of phage therapy in clinical practice","volume":"66","author":"Suh","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.copbio.2026.103527_bib61","doi-asserted-by":"crossref","DOI":"10.1007\/s00705-024-06170-9","article-title":"Designing a simple and efficient phage biocontainment system using the amber suppressor initiator tRNA","volume":"169","author":"Tsoumbris","year":"2024","journal-title":"Arch Virol"},{"key":"10.1016\/j.copbio.2026.103527_sbref62","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206739119","article-title":"Synthetic engineering and biological containment of bacteriophages","volume":"119","author":"Mitsunaka","year":"2022","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.copbio.2026.103527_bib63","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/med.21572","article-title":"Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review","volume":"39","author":"D\u0105browska","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.copbio.2026.103527_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162057","article-title":"Stability considerations for bacteriophages in liquid formulations designed for nebulization","volume":"12","author":"Flint","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.copbio.2026.103527_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2025.103693","article-title":"Advances in the production, purification, and concentration of bacteriophage bionanoparticles for biomedical applications","volume":"347","author":"Gao","year":"2026","journal-title":"Adv Colloid Interface Sci"},{"key":"10.1016\/j.copbio.2026.103527_bib66","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012435","article-title":"Biological foundations of successful bacteriophage therapy","volume":"14","author":"Venturini","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.copbio.2026.103527_bib67","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1039\/D3TB00991B","article-title":"Structural polymorphism in protein cages and virus-like particles","volume":"11","author":"Lie","year":"2023","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.copbio.2026.103527_bib68","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.copbio.2021.02.006","article-title":"Reprogramming bacteriophage host range: design principles and strategies for engineering receptor binding proteins","volume":"68","author":"Dunne","year":"2021","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.copbio.2026.103527_bib69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2019.09.015","article-title":"Engineering phage host-range and suppressing bacterial resistance through phage tail fiber mutagenesis","volume":"179","author":"Yehl","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.copbio.2026.103527_sbref70","article-title":"Generative design of novel bacteriophages with genome language models","author":"King","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.copbio.2026.103527_sbref71","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46585-1","article-title":"PHEIGES: all-cell-free phage synthesis and selection from engineered genomes","volume":"15","author":"Levrier","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.copbio.2026.103527_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065401","article-title":"Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial","volume":"12","author":"Khatami","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.copbio.2026.103527_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cell.2006.02.042","article-title":"A hybrid vector for ligand-directed tumor targeting and molecular imaging","volume":"125","author":"Hajitou","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.copbio.2026.103527_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113714","article-title":"Surface engineering of mesoporous bioactive glass nanoparticles with bacteriophages for enhanced antibacterial activity","volume":"234","author":"Meng","year":"2024","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.copbio.2026.103527_bib75","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/17460441.2024.2367023","article-title":"Phage display technology and its impact in the discovery of novel protein-based drugs","volume":"19","author":"Hutchings","year":"2024","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.copbio.2026.103527_bib76","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa1279","article-title":"In vivo phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues","volume":"49","author":"Pleiko","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.copbio.2026.103527_bib77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm0202-121","article-title":"Steps toward mapping the human vasculature by phage display","volume":"8","author":"Arap","year":"2002","journal-title":"Nat Med"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166926000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166926000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:00:50Z","timestamp":1787155250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166926000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":77,"alternative-id":["S0958166926000923"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2026.103527","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacteriophage nanoparticles: an emerging modular delivery platform","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2026.103527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103527"}}